MS7029 - Drug Discovery Technology (2017/18)
|Module specification||Module approved to run in 2017/18, but may be subject to modification|
|Module title||Drug Discovery Technology|
|Module level||Masters (07)|
|Credit rating for module||20|
|School||School of Human Sciences|
|Total study hours||200|
|Running in 2017/18||
This module is to provide an up-to-date understanding of chemical and biological technologies used in the drug discovery process.
Prior learning requirements
No pre-requisite modules are required
This module aims to provide:
(a) students with knowledge and understanding of how chemical and biological technologies are used in drug discovery process
(b) an opportunity for extensive in-depth research and critical assessment of a topical issue
• Overview of global trends in drug development
• Introduction to drug discovery: define key stages of drug discovery
• Structure based drug-design: Molecular modelling, bioinformatics. Trends in QSAR: From data analysis and model validation to drug design and discovery, Virtual screening, Chemical information & computing systems in drug discovery.
• Combinatorial chemistry and multiple parallel synthesis
• Validation and development of receptor targets and bioassays. High throughput screening technology
• Cutting edge technologies in drug discovery: X-ray crystallography, NMR, mass spectrometry, fluorescence spectroscopy and recombinant DNA technology
• Drug discovery case studies
Learning and teaching
Students will be provided with the opportunity to acquire knowledge of the subject matter through lectures (24 hours), seminars (8 hours) and tutorials (8 hours). Students' ability to obtain and critically appraise data, and identify related problems will be developed through directed reading and tutorial-based exercises. Students will be expected to reflect on taught material in order to demonstrate their understanding of the principles and practices of drug discovery technology covered in this module.
PDP: on completion of this module students’ provide an evaluation of how the module allowed them to develop skills such as information technology, organisational skills, team building, communication, time management, and working under pressure.
On successful completion of this module students will be able to:
1. Comprehensively describe, and accurately define the key stages of discovery process.
2. Demonstrate a deep understanding of new technologies in combinatorial chemistry and bioassays.
3. Critically evaluate and validate molecular targets.
4. Analyse and accurately interpret target-drug binding data from different cutting-edge technologies.
The module will be combatively assessed by means of a coursework component (40% of the overall mark) and an essay (60% of the overall mark). The coursework component will consist of one seminar presentation (40% of the overall mark). Coursework elements will also be used to provide formative feedback.
To pass the module students need to achieve a minimum aggregate mark of 50%.
Component - Learning outcomes
Seminar - 1, 2, 3
Essay - 1, 2, 3,4
Castanho M and Santos N (2011) Peptide Drug Discovery and Development: Translational Research in Academia and Industry. Wiley VCH.
Christ D (2011) In Vitro-in Vivo Correlations in Drug Discovery and Development: Concepts and Applications.
Patrick GL (2008) An Introduction to Medicinal Chemistry 4th Ed. Oxford.
Rang HP (2006) Drug Discovery and Development, Elsevier.
Yan Z-G and Caldwell G.W. ed (2004). Optimization in Drug Discovery: In Vitro Methods, Human Press